Ads
related to: what is daratumumab prescribed for in adults symptoms- DARZALEX® Side Effects
Find Information About Side Effects
Patients May Experience
- Preparing For Treatment
Watch a Video About What to Expect
Before, During, & After Treatment
- Cost Support Options
Learn About Potential Cost Support
Options Through Janssen CarePath
- Sign Up for Support
Register With Janssen CarePath to
Receive Support Program Information
- Read Patient Stories
Learn About the Treatment Journey
From Real Patients & Caregivers
- Nurse Support Program
Gain Access to Certified Nurses Who
Can Help Answer Treatment Questions
- DARZALEX® Side Effects
Search results
Results From The WOW.Com Content Network
Daratumumab, sold under the brand name Darzalex among others, is an anti-cancer monoclonal antibody medication. It binds to CD38 , [ 7 ] which is overexpressed in multiple myeloma cells. [ 8 ]
cryopyrin-associated periodic syndrome, Yao's Syndrome, Adult Onset Still's Disease: Cantuzumab mertansine [42] mab: humanized: CanAg (a glycoform of MUC1) colorectal cancer etc. Cantuzumab ravtansine [42] mab: humanized: CanAg (a glycoform of MUC1) cancers Caplacizumab [44] Cablivi: sdAb: humanized: VWF: Y: thrombotic thrombocytopenic purpura ...
It was approved for use in the United States in May 2020. [2] [7] [8]Efficacy of daratumumab and hyaluronidase-fihji (monotherapy) was evaluated in the COLUMBA trial (NCT03277105), an open-label non-inferiority trial randomizing 263 participants to daratumumab and hyaluronidase-fihj and 259 to intravenous daratumumab (daratumumab IV). [2]
The US Food and Drug Administration (FDA) approved durvalumab for certain types of bladder, lung, and biliary tract cancer: [6] [13] [14]. Adults with locally advanced or metastatic urothelial carcinoma who either have disease progression during or following platinum-containing chemotherapy or have disease progression within twelve months of neoadjuvant or adjuvant treatment with platinum ...
Around seven percent of U.S. adults can’t pay for prescription drugs they need, according to a 2021 Gallup poll. That’s an estimated 18 million people who say they had to go without at least ...
Elranatamab is indicated for the treatment of adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. [8] [12]
Ads
related to: what is daratumumab prescribed for in adults symptoms